Unusual initial manifestation of metastatic follicular carcinoma of the thyroid with thyrotoxicosis diagnosed by technetium Tc 99m pertechnetate scan: Case report and review of literature

Endocrine Practice

Volumn 15, Issue 5, 2009, Pages 458-462

  Sundaraiya, Sumati ^a   Dizdarevic, Sabina ^a   Miles, Kenneth ^b   Quin, John ^a   Williams, Anthony ^a   Wheatley, Trevor ^c   Zammitt, Charles ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c PRINCESS ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; IODINE 131; LEVOTHYROXINE; LIOTHYRONINE; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; THYROGLOBULIN; THYROTROPIN; THYROXINE; DIAGNOSTIC AGENT;

ABDOMINAL RADIOGRAPHY; AGED; ARTICLE; CALCIFICATION; CASE REPORT; CERVICAL SPINE RADIOGRAPHY; CLINICAL EXAMINATION; COLLOID CYST; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DYSPNEA; ELECTROCARDIOGRAM; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HAND TREMOR; HEART ATRIUM FIBRILLATION; HEART VENTRICLE; HISTOPATHOLOGY; HUMAN; IODINE 131 UPTAKE TEST; LIOTHYRONINE BLOOD LEVEL; MALE; MEDICAL LITERATURE; MESOTHELIOMA; METASTASIS; NORMOCHROMIC NORMOCYTIC ANEMIA; PATIENT REFERRAL; PLASMACYTOMA; PLEURA METASTASIS; POSTOPERATIVE PERIOD; PULSE RATE; RADIOACTIVITY; SCINTILLATION CAMERA; THORAX RADIOGRAPHY; THYROGLOBULIN BLOOD LEVEL; THYROID FOLLICULAR CARCINOMA; THYROID FUNCTION TEST; THYROID PARAFOLLICULAR CELL; THYROID SCINTISCANNING; THYROIDECTOMY; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION; ULTIMOBRANCHIAL BODY; WEAKNESS; WEIGHT REDUCTION; WHOLE BODY SCINTISCANNING; ADENOCARCINOMA; PATHOLOGY; RADIOGRAPHY; REVIEW; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; AGED; HUMANS; MALE; SODIUM PERTECHNETATE TC 99M; THYROID NEOPLASMS; THYROTOXICOSIS;

EID: 70449715882     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP08300.CRR     Document Type: Article

References (20)

1. Kasagi K, Takeuchi R, Miyamoto S, et al. Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases. Clin Endocrinol (Oxf). 1994;40:429-434.
2. Ishihara T, Ikekubo K, Shimodahira M, et al. A case of TSH receptor antibody-positive hyperthyroidism with functioning metastases of thyroid carcinoma. Endocr J. 2002;49:241-245.
3. Verma N, Singh-Wadhwa S, Arvela OM. Metastatic thyroid cancer visualized on technetium pertechnetate and iodine-131 scintigraphy. Clin Nucl Med. 2002;27:610.
4. Krausz Y, Horne T. Detection of metastatic thyroid carcinoma by 99mTc-pertechnetate in the presence of hyper-functioning thyroid tissue. J Surg Oncol. 1990;44:132-134.
5. Vieras F. Preoperative scintigraphic detection of cervical metastasis from thyroid carcinoma with technetium-99m pertechnetate. Clin Nucl Med. 1985;10:567-569.
6. Kiratli PO, Kara PP, Ergün EL, Gedikoǧlu G. Metastatic insular thyroid carcinoma: visualized on Tc-99m pertechnetate, Tc-99m MDP and iodine-131 scintigraphy; a review of the literature for other radionuclide agents. Ann Nucl Med. 2004;18:443-446.
7. Leiter L, Seidlin SM, Marinelli LD, Baumann EJ. Adenocarcinoma of the thyroid with hyperthyroidism and functional metastases. J Clin Endocrinol. 1946;6:247-261.
8. Paul SJ, Sisson JC. Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am. 1990;19:593-612.
9. Terzioǧlu T, Tezelman S, Onaran Y, Tanakol R. Concurrent hyperthyroidism and thyroid carcinoma. Br J Surg. 1993;80:1301-1302.
10. Bowden WD, Jones RE. Thyrotoxicosis associated with distant metastatic follicular carcinoma of the thyroid. South Med J. 1986;79:483-486.
11. Ober KP, Cowan RJ, Sevier RE, Poole GJ. Thyrotoxicosis caused by functioning metastatic thyroid carcinoma: a rare and elusive cause of hyperthyroidism with low radioactive iodine uptake. Clin Nucl Med. 1987;12:345-348.
12. Steffensen FH, Aunsholt NA. Hyperthyroidism associated with metastatic thyroid carcinoma. Clin Endocrinol (Oxf). 1994;41:685-687.
13. Yeo PP, Wang KW, Sinniah R, et al. Thyrotoxicosis and thyroid cancer. Aust N Z J Med. 1982;12:589-593.
14. Rosário F, Marques AR, Roque L, et al. Metastatic follicular carcinoma associated with hyperthyroidism. Clin Nucl Med. 2005;30:79-82.
15. Stocker DJ, Burch HB. Thyroid cancer yield in patients with Graves' disease. Minerva Endocrinol. 2003;28: 205-212.
16. Sahin M, Guvener ND, Ozer F, Sengul A, Ertugrul D, Tutuncu NB. Thyroid cancer in hyperthyroidism: incidence rates and value of ultrasound-guided fine-needle aspiration biopsy in this patient group. J Endocrinol Invest. 2005;28:815-818.
17. Kraimps JL, Bouin-Pineau MH, Mathonnet M, et al. Multicentre study of thyroid nodules in patients with Graves' disease. Br J Surg. 2000;87:1111-1113.
18. Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med. 2002;43:1188-1200.
19. Park HJ, Kim JY, Park KY, Gong G, Hong SJ, Ahn IM. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Thyroid. 2000;10:211-217.
20. Lin JD, Chan EC, Chao TC, et al. Expression of sodium iodide symporter in metastatic and follicular human thyroid tissues. Ann Oncol. 2000;11:625-629.